Answers are grounded in this paper and cite their sources.
Riboflavin, vitamin B2, is a precursor to the coenzymes FMN and FAD, and a required daily nutrient. Flavins are essential to metabolic processes due to their roles in redox reactions critical to energy production and synthesis of new molecules. While riboflavin deficiency was thought to be rare, recent evidence suggests that several diseases, including cancer and metabolic syndromes, can be ascribed to insufficient riboflavin. Assessing individuals for vitamin status is difficult for riboflavin, as no simple and inexpensive test is available. This research demonstrates the potential of a novel molecule that can be used in research and detection. A series of riboflavin derivatives have been synthesized with the intention of observing their binding capabilities, particularly to riboflavin-binding protein. It has been demonstrated that the analogs retain their ability to bind to riboflavin-binding protein. This opens the applications of these derivatives to be further explored. University of Michigan-Dearborn campus grants.
No takes yet. Share an insight, caveat, or question.
Branscum et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: